LEADER 04403nam 2200685Ia 450 001 9910818978003321 005 20200520144314.0 010 $a1-281-31020-4 010 $a9786611310202 010 $a0-470-69388-6 010 $a0-470-69310-X 035 $a(CKB)1000000000411655 035 $a(EBL)350950 035 $a(OCoLC)437213966 035 $a(SSID)ssj0000289350 035 $a(PQKBManifestationID)11221474 035 $a(PQKBTitleCode)TC0000289350 035 $a(PQKBWorkID)10385448 035 $a(PQKB)10076618 035 $a(MiAaPQ)EBC350950 035 $a(Au-PeEL)EBL350950 035 $a(CaPaEBR)ebr10232819 035 $a(CaONFJC)MIL131020 035 $a(EXLCZ)991000000000411655 100 $a20010320d2002 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAsthma $ecritical debates /$fedited by Sebastian L. Johnston, Stephen T. Holgate 205 $a1st ed. 210 $aLondon ;$aMalden, MA $cBlackwell Science$d2002 215 $a1 online resource (410 p.) 225 1 $aChallenges In 300 $aDescription based upon print version of record. 311 $a0-632-05721-1 320 $aIncludes bibliographical references and index. 327 $aAsthma; Contents; List of contributors; Preface; Acknowledgements; Part 1: Epidemiology; 1 P.M.MATRICARDI AND S. BONINI: Why is the incidence of asthma increasing?; 2 E. VON MUTIUS: Why is asthma more common in the West?; 3 R. BEASLEY, J. DOUWES, J. PEKKANEN AND N.E. PEARCE: How much asthma can be attributed to atopic sensitization?; 4 A.J. CHAUHAN: Is air pollution important in asthma?; Part 2: Pathophysiology; 5 E.R. SUTHERLAND AND R.J. MARTIN: Is infection important in the pathogenesis and clinical expression of asthma? 327 $a6 B. BJORKSTEN: Does infection in early life protect against or cause asthma?7 S.T. WEISS: Does asthma progress to chronic obstructive pulmonary disease?; 8 P.G. WOODRUFF, S.L. PRESCOTT, P.G. HOLT AND J.V. FAHY: Antenatal factors in the development of atopy and asthama?; 9 I. SAYERS, B. BEGHE, J. HOLLOWAY AND S.T. HOLGATE: Genetics of asthma: what's new?; Part 3: Treatment; 10 D. SMALLWOOD AND J. WILSON: Can airway fibrosis be prevented?; 11 A. CUSTOVIC AND A. WOODCOCK: Does allergen avoidance help? What are the practical measures that patients can take? 327 $a12 P.J. HELMS: Is early treatment of children necessary?13 P.J. BARNES: What are the mechanisms of corticosteroid resistance in asthma?; 14 J.C. KIPS, K.G. TOURNOY AND R.A. PAUWELS: What new therapies are being developed for asthma and will they offer something better than steroids?; 15 M.R . SEARS: What is the role of long-acting (32-agonists in the treatment of asthma?; 16 M.E. WECHSLER AND J.M. DRAZEN: What is the role of leukotriene modifiers in the treatment of asthma?; Part 4: Delivery of Care; 17 D. PRICE: What are the issues in delivering care in primary care? 327 $a18 B.D.W. HARRISON AND S.M. MILDENHALL: Are asthma clinics useful: should they be run by the doctor or the nurse?19 M.R. PARTRIDGE: Should asthma be managed by the patient or the doctor: is education important?; 20 B.D.W. HARRISON AND S.M. MILDENHALL: Are psychosocial factors important in asthma?; Index 330 $aAsthma is one of the most important diseases affecting our society. It is an extremely common condition that reduces quality of life, and acute exacerbations can be life-threatening. It affects a disproportionate number of children. With the overwhelming volume of research being carried out in this field specialists need a method of keeping up-to-date with current opinion. As with the other 'Challenges' books, 'Challenges in Asthma' is aimed at hospital specialists and therefore assumes a certain level of knowledge about the disease. It builds on this by discussing only areas of controversy 410 0$aChallenges In 517 3 $aAsthma 606 $aAsthma 606 $aLungs$xDiseases, Obstructive 615 0$aAsthma. 615 0$aLungs$xDiseases, Obstructive. 676 $a616.2/38 676 $a616.238 701 $aJohnston$b Sebastian L$0905003 701 $aHolgate$b S. T$0878514 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818978003321 996 $aAsthma$92024063 997 $aUNINA